Suppr超能文献

亚临床甲状腺功能减退与日本非糖尿病受试者的蛋白尿有关。

Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects.

作者信息

Toda Akiko, Hara Shigeko, Tsuji Hiroshi, Arase Yasuji

机构信息

Health Management Center, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo, 105-8470, Japan.

出版信息

Endocrine. 2020 Jun;68(3):592-598. doi: 10.1007/s12020-020-02220-9. Epub 2020 Feb 14.

Abstract

PURPOSE

Thyroid dysfunction is a risk factor of cardiovascular disease (CVD), and albuminuria is a predictor of CVD. For preventing the CVD, it is essential to clarify from which stage of thyroid dysfunction the risk of CVD starts developing. We thus investigated the association between subclinical thyroid dysfunction and albuminuria, focusing on a nondiabetic general population.

METHODS

We analyzed the data of 17,221 nondiabetic subjects who underwent annual health checkups by multivariate logistic regression analyses.

RESULTS

Compared with the subjects with euthyroidism, those with subclinical hypothyroidism presented a higher prevalence of albuminuria. By a multivariate logistic regression analysis, subclinical hypothyroidism showed a significant and independent association with the high prevalence of albuminuria compared with euthyroidism (OR 1.64, 95% CI 1.21-2.21, p = 0.001). In accord with this result, the analysis in which the lowest quartile of thyroid stimulating hormone (TSH) concentration (<0.96 µIU/mL) was used as a reference revealed that the highest quartile (>2.07 µIU/mL) had a significant and independent association with the prevalence of albuminuria (OR 1.23, 95% CI 1.01-1.51, p = 0.04). One microliter unit per milliliter increase of the serum concentration of TSH also had a significant and independent association with the prevalence of albuminuria (OR 1.07, 95% CI 1.02-1.12, p = 0.006). The association between subclinical hyperthyroidism and the prevalence of albuminuria was not significant.

CONCLUSION

Our data indicated that subclinical hypothyroidism was significantly and independently associated with the high prevalence of albuminuria.

摘要

目的

甲状腺功能障碍是心血管疾病(CVD)的一个危险因素,而蛋白尿是CVD的一个预测指标。为预防CVD,明确甲状腺功能障碍从哪个阶段开始增加CVD风险至关重要。因此,我们针对非糖尿病普通人群,研究了亚临床甲状腺功能障碍与蛋白尿之间的关联。

方法

我们通过多因素逻辑回归分析,对17221名接受年度健康检查的非糖尿病受试者的数据进行了分析。

结果

与甲状腺功能正常的受试者相比,亚临床甲状腺功能减退的受试者蛋白尿患病率更高。通过多因素逻辑回归分析,与甲状腺功能正常相比,亚临床甲状腺功能减退与蛋白尿的高患病率存在显著且独立的关联(比值比1.64,95%置信区间1.21 - 2.21,p = 0.001)。与此结果一致,以促甲状腺激素(TSH)浓度最低四分位数(<0.96 μIU/mL)作为参照的分析显示,最高四分位数(>2.07 μIU/mL)与蛋白尿患病率存在显著且独立的关联(比值比1.23,95%置信区间1.01 - 1.51,p = 0.04)。血清TSH浓度每增加1 μIU/mL也与蛋白尿患病率存在显著且独立的关联(比值比1.07,95%置信区间1.02 - 1.12,p = 0.006)。亚临床甲状腺功能亢进与蛋白尿患病率之间的关联不显著。

结论

我们的数据表明,亚临床甲状腺功能减退与蛋白尿的高患病率存在显著且独立的关联。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验